Literature DB >> 9890677

Cytokines and soluble CD4 and CD8 molecules in rheumatoid arthritis: relationship to systematic vasculitis and microvascular capillaroscopic abnormalities.

A Kuryliszyn-Moskal1.   

Abstract

Vascular involvement in rheumatoid arthritis (RA) is associated with a wide range of extra-articular complications. Damage to internal organs occurs through a widespread disorder of the microvasculature. Vasculitis, as an integral part of the disease process, is associated with immune system abnormalities. To evaluate the relationship between capillaroscopic abnormalities, extra-articular involvement and immunological alterations, serum levels of soluble CD4 (sCD4), CD8 (sCD8), tumour necrosis factor alpha (TNF-alpha), interleukin-6 (IL-6) and soluble interleukin-6 receptor (sIL-6R) were determined by an enzyme-linked immunosorbent assay in 80 RA patients. In all patients with signs of extra-articular manifestations, severe or moderate changes in nailfold capillaroscopy were found. Serum levels of TNF-alpha, IL-6, sIL-6R and sCD4 were significantly higher in RA patients compared with 30 healthy subjects. RA patients with clinical signs of systemic vasculitis showed significantly higher levels of TNF-alpha and IL-6 compared with those without vascular involvement. Moreover, a significant correlation between sCD4 levels and the capillaroscopy findings was found. These results point to a pathogenic role of the cytokine network in rheumatoid vasculitis and further may suggest an important role of cellular immune activation in the pathogenesis of microvascular damage.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9890677     DOI: 10.1007/bf01451285

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  34 in total

1.  Serum soluble CD4 and CD8 levels in Kawasaki disease.

Authors:  S Furukawa; T Matsubara; K Tsuji; T Motohashi; K Okumura; K Yabuta
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

2.  Soluble CD8 in patients with rheumatic diseases.

Authors:  J A Symons; N C Wood; F S di Giovine; G W Duff
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

3.  Patterns of finger capillary abnormalities in connective tissue disease by "wide-field" microscopy.

Authors:  H R Maricq; E C LeRoy
Journal:  Arthritis Rheum       Date:  1973 Sep-Oct

4.  "Wide-field" photography of nailfold capillary bed and a scale of plexus visualization scores (PVS).

Authors:  H R Maricq
Journal:  Microvasc Res       Date:  1970-07       Impact factor: 3.514

5.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

6.  Serial estimation of interleukin 6 as a measure of systemic disease in rheumatoid arthritis.

Authors:  B Dasgupta; M Corkill; B Kirkham; T Gibson; G Panayi
Journal:  J Rheumatol       Date:  1992-01       Impact factor: 4.666

7.  Serum levels of interleukin-1b, tumour necrosis factor-a and interleukin-2 in rheumatoid arthritis. Correlation with disease activity.

Authors:  L Altomonte; A Zoli; L Mirone; P Scolieri; M Magaró
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

8.  Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis.

Authors:  C Tetta; G Camussi; V Modena; C Di Vittorio; C Baglioni
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

9.  Soluble CD4 in patients with rheumatoid arthritis and osteoarthritis.

Authors:  J A Symons; J F McCulloch; N C Wood; G W Duff
Journal:  Clin Immunol Immunopathol       Date:  1991-07

10.  Survival, prognosis, and causes of death in rheumatoid arthritis.

Authors:  D M Mitchell; P W Spitz; D Y Young; D A Bloch; D J McShane; J F Fries
Journal:  Arthritis Rheum       Date:  1986-06
View more
  8 in total

1.  Soluble CD4 concentrations predict relapse of post-partum thyroiditis.

Authors:  C Balázs; N R Farid
Journal:  J Endocrinol Invest       Date:  2002-01       Impact factor: 4.256

Review 2.  Vasculitis in the connective tissue diseases.

Authors:  D Alarcón-Segovia
Journal:  Curr Rheumatol Rep       Date:  2000-10       Impact factor: 4.592

3.  Analysis of correlations between selected endothelial cell activation markers, disease activity, and nailfold capillaroscopy microvascular changes in systemic lupus erythematosus patients.

Authors:  Mariusz Ciołkiewicz; Anna Kuryliszyn-Moskal; Piotr Adrian Klimiuk
Journal:  Clin Rheumatol       Date:  2009-11-12       Impact factor: 2.980

4.  Capillaroscopy in psoriatic and rheumatoid arthritis: a useful tool for differential diagnosis.

Authors:  Dario Graceffa; Beatrice Amorosi; Elisa Maiani; Claudio Bonifati; Maria Sole Chimenti; Roberto Perricone; Aldo Di Carlo
Journal:  Arthritis       Date:  2013-12-12

5.  Identification of venular capillary remodelling: a possible link to the development of periodontitis?

Authors:  David Townsend
Journal:  J Periodontal Implant Sci       Date:  2022-02       Impact factor: 2.614

Review 6.  Nailfold Videocapillaroscopy for the Evaluation of Peripheral Microangiopathy in Rheumatoid Arthritis.

Authors:  Panagiota Anyfanti; Elena Angeloudi; Athanasia Dara; Alexandra Arvanitaki; Eleni Bekiari; George D Kitas; Theodoros Dimitroulas
Journal:  Life (Basel)       Date:  2022-07-31

7.  Circulating E-selectin and tumor necrosis factor-alpha in extraarticular involvement and joint disease activity in rheumatoid arthritis.

Authors:  Esther G Corona-Sanchez; Laura Gonzalez-Lopez; Jose F Muñoz-Valle; Monica Vazquez-Del Mercado; Maria A Lopez-Olivo; Erika A Aguilar-Chavez; Mario Salazar-Paramo; Carlos Loaiza-Cardenas; Edith Oregon-Romero; Rosa E Navarro-Hernandez; Jorge I Gamez-Nava
Journal:  Rheumatol Int       Date:  2008-08-23       Impact factor: 3.580

8.  Vascular endothelial growth factor in systemic lupus erythematosus: relationship to disease activity, systemic organ manifestation, and nailfold capillaroscopic abnormalities.

Authors:  Anna Kuryliszyn-Moskal; Piotr Adrian Klimiuk; Stanisław Sierakowski; Mariusz Ciołkiewicz
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-06-08       Impact factor: 4.291

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.